Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has announcements × Advanced Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 19 Multiple Myeloma 16 Breast Neoplasms 16 Neoplasms 15 Leukemia, Myeloid, Acute 13 Recurrence 10 Colorectal Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myelodysplastic Syndromes 8 Melanoma 8 Lymphoma, Non-Hodgkin 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 8 Lymphoma, Follicular 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 7 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Uterine Cervical Neoplasms 5 Purpura, Thrombocytopenic, Idiopathic 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, Mantle-Cell 5 Lung Neoplasms 5 Esophageal Neoplasms 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Prostatic Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02743494 2025-11-18

CheckMate 577

Bristol-Myers Squibb

Phase 3 Completed

794 enrolled 13 charts 1 FDA

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡